BOSTON SCIENTIFIC CORPORATION Repurchase Agreement Counterparty, Amount at Risk
BOSTON SCIENTIFIC CORPORATION (BSX) had Repurchase Agreement Counterparty, Amount at Risk of $1.01 as of 2019-12-31, per its 10-K filed 2020-02-25.
Discontinued › Notes › Transfers and Servicing
us-gaap:RepurchaseAgreementCounterpartyAmountAtRisk · last filed 2020-02-25
- 2019-12-31: Repurchase Agreement Counterparty, Amount at Risk $1.01.
- 2018-12-31: Repurchase Agreement Counterparty, Amount at Risk $1.01.
- 2017-12-31: Repurchase Agreement Counterparty, Amount at Risk $1.01.
- 2016-12-31: Repurchase Agreement Counterparty, Amount at Risk $1.01.
| Period end | Repurchase Agreement Counterparty, Amount at Risk |
|---|---|
| 2019-12-31 | $1.01 10-K · filed 2020-02-25 |
| 2018-12-31 | $1.01 10-K · filed 2019-02-19 |
| 2017-12-31 | $1.01 10-K · filed 2018-02-20 |
| 2016-12-31 | $1.01 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |